Drug Information Update- New From Our Perspective: Expedited oncology drug approvals

The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.

A new From our perspective article on expedited oncology drug approvals was posted today. This piece features Dr. Richard Pazdur. In the article, Dr. Pazdur highlights some of the 2015 approvals of the Office of Hematology and Oncology Products and discusses a few of the expedited review programs that are used by the office.

More from Richard Pazdur, M.D.

From our perspective: The Collection